|
The Impact of Tobacco Use on Oral Health and the Oral Microbiome
|
Research Initiative
|
CDC, FDA
|
NCI
|
The US Food and Drug Administration Intramural Center of Tobacco Regulatory Science Award Program funded a project examining how tobacco affects oral health and the oral microbiome in the National Health and Nutrition Examination Survey (NHANES) study.
|
|
The Incidence of Breast and Other Cancers Among Female Flight Attendants
|
Research Initiative
|
CDC
|
NCI
|
A cohort study of approximately 10,000 Pan Am flight attendants to determine cancer incidence (primarily breast cancer) associated with cosmic radiation and circadian disruption from their work.
|
|
The Interagency Committee on Human Nutrition Research (ICHNR)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, HRSA
|
NIDDK
|
The Interagency Committee on Human Nutrition Research (ICHRN) is charged with improving the planning, coordination, and communication among federal agencies engaged in nutrition research.
|
|
The Interagency Committee on Human Nutrition Research (ICHNR) Dietary Guidelines Subcommittee
|
Committee, Work group, Advisory group, or Task Force
|
OS
|
NICHD
|
The Interagency Committee on Human Nutrition Research (ICHNR) dietary guidelines subcommittee serves to improve planning, coordination, and communication among federal agencies engaged in research in nutrition and/or nutrition policies, surveillance, technologies, and related issues. The key focus of the Subcommittee on Dietary Guidelines is to gain perspectives from Federal stakeholders regarding the Dietary Guidelines Advisory Committee''s (DGAC) deliberations and identify any gaps or concerns that are important to Federal programs and to engage USDA and HHS agencies in the DGA policy development process.
|
|
The MDEpiNet TMJ RoundTable
|
Meeting/ Workshop
|
AHRQ, FDA
|
NIDCR
|
This workshop facilitated collaboration of stakeholders to address data on implant performance, surgical outcomes, and adverse events in an effort to: develop outcome and assessment and reporting tools based on patient input, the intersection of patient biology, anatomy, genetics, physiology with TMJ medical devices, and clinical patient-centered outcomes to better target therapies.
|
|
The Mental Health Block Grant Ten Percent Set Aside (MHBG) Evaluation
|
Other
|
SAMHSA
|
NIMH
|
The Substance Abuse and Mental Health Services Administration (SAMHSA) is sponsoring an evaluation of first episode psychosis treatment programs funded through the federal 10 percent Mental Health Block Grant Set Aside. Through an inter-agency agreement, the National Institute of Mental Health (NIMH) is co-funding the evaluation and is actively involved in all phases of the evaluation design and planning.
|
|
The Nanoscale Science, Engineering, and Technology (NSET) Subcommittee
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA
|
NCI, NIBIB, OD/OSP
|
This subcommittee of the National Science and Technology Council''s Committee on Technology is responsible for coordinating the National Nanotechnology Initiative (NNI). The NNI was established in 2001 to coordinate federal research and development in nanotechnology by providing a vision of the long-term benefits and opportunities offered by nanotechnology and acting as a locus for communication, cooperation, and collaboration between federal agencies involved in nanotechnology research and development. In 2016, the NSET updated its strategic plan to reflect the fact that nanotechnology is now a broadly enabling technology, not simply an area of research at the nanoscale. The new strategic plan outlines four goals: (1) advance a world-class nanotechnology research and development program, (2) foster the transfer of new technologies into products for commercial and public benefit, (3) develop and sustain educational resources, a skilled workforce, and a dynamic infrastructure and toolset to advance nanotechnology, and (4) support responsible development of nanotechnology.
|
|
The NIH Helping to End Addiction Long Term (HEAL) Initiative
|
Research Initiative
|
AHRQ, CDC, CMS, HRSA, OS, SAMHSA
|
NIDA, NCATS, NCCIH, NHLBI, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDDK, NIMH, NINDS, OD/OSP
|
In April 2018, NIH launched the HEAL (Helping to End Addiction Long-termSM) Initiative, an aggressive, trans-agency effort to speed scientific solutions to stem the national opioid public health crisis. This Initiative will build on extensive, well-established NIH research, including basic science of the complex neurological pathways involved in pain and addiction, implementation science to develop and test treatment models, and research to integrate behavioral interventions with Medication-Assisted Treatment (MAT) for opioid use disorder (OUD) The NIH HEAL Initiative℠ will bolster research across NIH to improve treatments for opioid misuse and addiction and enhance pain management.
|
|
The OAR-organized Fogarty International Center and HRSA HIV/AIDS Bureau Collaborative Meeting on the Integration of HIV Care and Non-Communicable Diseases
|
Committee, Work group, Advisory group, or Task Force
|
HRSA
|
OD/DPCPSI/OAR, FIC
|
The goal of this meeting was for FIC/NIH to have the benefit of a consult with HRSA staff familiar with the Ryan White HIV/AIDS Program and possibly other HIV/AIDS service programs that will be informative in relation to a new initiative FIC is planning. This initiative will be services research where non-HIV/AIDS health issues will be built into current HIV/AIDS services platforms with the goal of developing models of care that more efficiently address HIV/AIDS and other health service needs of the clients served. This will be international research.
|
|
The Science of Sex and Gender in Human Health
|
Training Initiative
|
FDA
|
OD/DPCPSI/ORWH
|
The new online sex and gender course, Sex and Gender Influences in Health and Disease: From Bench to Bedside, currently in development consists of a series of modules based on clinical topics (immunology, cardiovascular disease, mental health, pulmonary, neurology, and endocrinology). The goal of the course is for learners to gain an understanding of sex and gender influences on health and disease, as well as how these influences can be studied and to integrate those concepts into their research and practice. The material showcases examples from basic science through clinical trials and translation to practice to help ensure participants understand the importance of considering the influence of sex and gender throughout the research spectrum and beyond. This course is being developed by the NIH Office of Research on Women’s Health in collaboration with the FDA Office of Women’s Health. It will offer free CEUs in a variety of disciples and be available worldwide. The first module is expected to be available in spring of 2019.
|